A review of 6 placebo-managed clinical trials with 1,134 whole contributors concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) were associated with a higher normal improvement within the Ashworth scale for spasticity in a number of sclerosis clients as opposed with placebo, although this did not reach statistical significance. Contingency https://stephenhbnpr.pages10.com/new-step-by-step-map-for-thc-69742083